CF
ACIU icon

Cantor Fitzgerald’s AC Immune ACIU Stock Holding History

Cantor Fitzgerald’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$60.9K – 367
2025
Q2 		$60.9K Buy
30,000
+10,000
+50% +$17.4K ﹤0.01% 370
2025
Q1 		$37.4K Sell
20,000
-5,000
-20% -$12.6K ﹤0.01% 261
2024
Q4 		$67.5K Buy
+25,000
New +$78.1K ﹤0.01% 220

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cantor Fitzgerald's ACIU Position: Q3 2025 in Review

Cantor Fitzgerald sold out of AC Immune (ACIU) in Q3 2025, closing a stake of 30,000 shares — an estimated $60.9K sold.

Cantor Fitzgerald first reported a position in ACIU in Q4 2024 and held it in 3 quarters. The position peaked at $67.5K in Q4 2024. 40 funds tracked by Wall St. Rank hold ACIU as of Q3 2025.

  • Cantor Fitzgerald reported no remaining AC Immune position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 30,000 AC Immune shares in Q3 2025, an estimated $60.9K.
  • Cantor Fitzgerald first reported a position in AC Immune in Q4 2024 and held it in 3 quarters.
  • Cantor Fitzgerald's AC Immune position peaked at $67.5K in Q4 2024.
  • 40 funds tracked by Wall St. Rank held AC Immune as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.